Table 2.
Evaluation of deconvolution pipelines with real mixtures.
| Heterogeneous input | Reference matrix | Marker information | Expected proportions | |
|---|---|---|---|---|
| Bulk deconvolution methodologies | 9 human bulk PBMCs | Bulk RNA-seq of monocytes, B cells, natural killer, dendritic cells and T cells (SRA accession from Supplementary Table 1) | Markers for monocytes, B cells, natural killer, dendritic cells and T cells obtained from 10x scRNA-seq data | Flow cytometry measurements |
| Deconvolution methods using scRNA-seq as reference | 9 human bulk PBMCs | 10× scRNA-seq data excluding CD34+ cells | No prior information | Flow cytometry measurements |
Scenarios used to assess the performance of the different deconvolution methods using bulk RNA-seq from nine PBMCs samples.